Browse the glossary using this index
Special | A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | ALL
Council for International Organisations of Medical Sciences
Council for International Organisations of Medical Sciences (CIOMS) http://www.cioms.ch/"
Council of Health Ministers
Council of Health Ministers (CDSP) http://www.coe.int/t/dg3/health/CDSP_en.asp"
Criteria for 'go/no-go' decisions
Compounds under investigation as potential new medicines must meet certain criteria, at each stage of development, in order to progress further. These criteria need to be agreed upon by the medicines developers. A go™ decision means that the compound meets the criteria, and will be advanced to the next development step. Failure to meet the criteria will lead to a no-go™ decision and the medicine development will stop.
A cross-sectional study is one type of observational study, in which the researcher does not perform any intervention (such as administering a medicine).
Cross-sectional studies are primarily used to find out how many cases of a disease are present in a population at a given point in time (called 'prevalence'). They are used to assess the health needs of a population and are useful in planning and allocating health resources. Cross-sectional studies are generally performed by survey/questionnaire or interview.